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The endoplasmic reticulum (ER) is a cellular organelle responsible for multiple important cellular functions including the
biosynthesis and folding of newly synthesized proteins destined for secretion, such as insulin. The ER participates in all branches
of metabolism, linking nutrient sensing to cellular signaling. Many pathological and physiological factors perturb ER function
and induce ER stress. ER stress triggers an adaptive signaling cascade, called the unfolded protein response (UPR), to relieve
the stress. The failure of the UPR to resolve ER stress leads to pathological conditions such as β-cell dysfunction and death,
and type II diabetes. However, much less is known about the ﬁne details of the control and regulation of the ER response
to hyperglycemia (glucotoxicity), hyperlipidemia (lipotoxicity), and the combination of both (glucolipotoxicity). This paper
considers recent insights into how the response is regulated, which may provide clues into the mechanism of ER stress-mediated
β-cell dysfunction and death during the progression of glucolipotoxicity-induced type II diabetes.
1.Introduction
Type II diabetes is a heterogeneous syndrome resulting
from progressive impairment of β-cell insulin secretion
and insulin resistance in target tissues. Prevalence of type
II diabetes, in which the body attempts to compensate
for insulin resistance by augmenting insulin secretion, has
increased because of the rising rate of obesity [1]. However,
it is increasingly clear that pancreatic β-cell dysfunction
also contributes to type II diabetes [2]. Healthy pancreatic
β-cells display a dramatic response to nutrients and to
obesity-associated insulin resistance through hypersecretion
ofinsulintomaintainenergyhomeostasis.But,intypeIIdia-
betes, β-cells are unable to sustain a compensatory response,
leading to β-cell dysfunction and death [3]. Although the
cause of the metabolic deterioration is unknown, several
hypotheses have been proposed, including mitochondrial
dysfunction, oxidative stress, ER stress, hyperglycemia (glu-
cotoxicity), dyslipidemia (lipotoxicity), and the combination
of both (glucolipotoxicity) [4–7].
Recentstudieshavesuggestedthatelevatedglucose,along
with circulating free fatty acids (FFAs), and particularly
those originating from intra-abdominal fat stores are the
major culprits in insulin resistance and β-cell dysfunction
[6, 7]. The chronic hyperglycemia and hyperlipidemia cause
combined,detrimentaleﬀectsdeﬁnedasglucolipotoxicityon
β-cell function and survival [7]. However, the underlying
molecular and cellular mechanisms by which glucolipotox-
icity contributes to β-cell dysfunction and death in type II
diabetes remain under debate. A recent observation based
on experimental, clinical, and genetic evidence suggests that
the endoplasmic reticulum (ER) may be responsible for the
molecular mechanisms of glucolipotoxicity contributing to
β-cell dysfunction in type II diabetes [8, 9]. In this paper, we
discuss the involvement of ER in glucolipotoxicity-induced
β-cell dysfunction and death along with the involvement of
mitochondria.
2. ERStress Response
Pancreatic β-cells display a marked response to nutrient
signals through balance between the anabolic hormone
insulin and the catabolic hormone glucagon, which are used2 Experimental Diabetes Research
to maintain energy homeostasis. To mount an appropriate
response, pancreatic β-cells require suitable sensors and sig-
naling molecules, which integrate these signals to modulate
insulin secretion to maintain homeostasis.
The ER is an integral contributor to protein synthesis,
folding, maturation, traﬃcking, and degradation, and it
may be an ideal site for nutrient sensation at the subcel-
lular level [10]. The quality control machinery of the ER
operates via specialized proteins and a speciﬁc chemical
environment to ensure proper folding and processing of
secretory proteins, and degradation of misfolded/unfolded
proteins, including insulin, to maintain glucose home-
ostasis. However, overloading this machinery causes the
more accumulation of misfolded/unfolded proteins in the
ER and reduces the quality and quantity of ER, leading
to ER stress [11]. To cope with this condition, cells
activate an adaptive system linking the ER lumen with
the cytoplasm and nucleus called the unfolded protein
response (UPR). The UPR restores ER homeostasis, by
attenuating global protein translation to decrease the protein
overload and by increasing the expression of genes that
induce protein folding and also promote ER-associated
protein degradation (ERAD) to remove misfolded proteins
[12].
The three branches of the UPR are mediated by the
ER-membrane associated proteins PERK (protein kinase R-
like ER kinase), IRE1α (Inositol requiring enzyme 1), and
ATF6 (activating transcription factor 6). Under unstressed
conditions, these three proteins are held by the abundant
ER chaperone Bip/glucose-regulated protein 78 (GRP78) at
the N-terminal domains of PERK and IRE1α and at the
carboxyl terminal of ATF6, preventing their aggregation and
rendering them inactive [13]. Under ER stress conditions,
PERK is autophosphorylated and in turn phosphorylates
serine 51 of eukaryotic translation initiation factor 2α
(eif2α), rendering it unable to eﬃciently initiate translation,
leading to global inhibition of protein synthesis and at
the same time inducing translation of the transcription
factor ATF4. ATF4 protein translocates to the nucleus
and upregulates ER stress target genes, including C/EBP
homologousprotein(CHOP)anddownstreamgrowtharrest
and DNA damage-inducible protein (GADD34) that acts as
a nonenzymatic cofactor for protein phosphatase-1 (PP-1),
leadingtoeif2αdephosphorylationfortranslationalrecovery
[14, 15].
Under ER stress condition, activation of ATF6 involves
the dissociation of Bip/GRP78 from its luminal domain
and translocation to the Golgi for proteolytic processing
where it is cleaved into its active form, which translocates
into the nucleus to induce chaperon protein genes such
as Bip/GRP78, GPR94, and calreticulin to enhance protein
folding [16]. IRE1α, the third ER stress sensor, is a type
1 transmembrane protein with endoribonuclease activity.
Similar to PERK, IRE1α is autophosphorylated in response
to accumulation of misfolded/unfolded proteins in the ER.
Once activated, IRE1α catalyzes the splicing of X-box-
binding protein 1 (XBP-1) mRNA, leading to translation
of the active transcription factor XBP-1 that induces the
expression of genes required for protein folding, ER to Golgi
transport, and endoplasmic-reticulum-associated protein
degradation (ERAD) [17].
3. UPR underGlucolipoadaptationin β-Cells
Adaptation to metabolic changes requires regulation and
coordination of many homeostatic systems, since the quality
and quantity of available nutrients does not temporally
match cellular needs. Acute exposure of β-cells to high glu-
cose induces mild UPR signaling accompanied by phospho-
rylation and activation of IRE1α, leading to glucose-induced
insulin biosynthesis [18]. Conversely, inactivation of IRE1α
signaling by siRNA or inhibition of IRE1α phosphorylation
hinders glucose-induced insulin biosynthesis, indicating that
acute IRE1α activation is required for proinsulin biosyn-
thesis. Surprisingly, however, acute high glucose-induced
IRE1α was found not to splice the downstream target XBP-1,
implying that IREα-mediated XBP-1 splicing is not essential
for proinsulin biosynthesis.
Another study suggested that transient high glucose
upregulates the ER resident protein oxidoreductase 1α
(ERO1α), an activator of protein disulﬁde isomerase (PDI),
which plays an important role in disulﬁde bond forma-
tion. Thus, ERO1α may activate insulin biosynthesis by
enhancing disulﬁde bond formation in proinsulin in the
ER [19]. Rutkowski and Kaufman suggested that eif2α
phosphorylation limits proinsulin mRNA translation under
low-glucose condition [10]. However, paradoxically, eif2a
phosphorylation seems to be needed to upregulate proin-
sulin mRNA translation to compromise the uncontrolled
insulin translation in response to physiologic intermittent
h i g hg l u c o s el e v e l s[ 11]. Steady-state eif2α phosphorylation
in glucose-induced protein translation is short, and it
can be rapidly dephosphorylated by physiological stim-
uli via a signaling pathway that activates GADD34 and
PPI [20].
In parallel with glucose, saturated and unsaturated FFAs
elicit quantitatively and qualitatively diﬀerent ER stress sig-
naling in β-cells. Most investigators have employed palmitate
or oleate as the fatty acids of choice because they represent
the major species to which β-cells might be exposed in vivo
[21]. However, considering the speciﬁc eﬀects of fatty acids
on β-cell viability, palmitate is more potent than oleate in
triggering ER stress in clonal and primary rodent β-cells,
and in human islets [22–24]. Exposure to long-chain FFAs
within the physiologic range can directly stimulate insulin
secretion through changes in ER calcium (Ca2+) handling
[25].ERisthoughttobethemaindynamicintracellularCa2+
storage compartment in β-cells. Palmitate causes increases in
phosphorylation of the PERK branch and IRE1α-activated
spliced form of XBP-1, but the eﬀects of oleate are much
less signiﬁcant [26]. The marked activation of PERK-eif2α
phosphorylation by palmitate leads to the induction of ATF4
and CHOP expression, which results in inhibition of protein
translation [27]. Thus, FFAs diﬀerentially regulate the UPR
response under physiological conditions to maintain home-
ostasis. Growing evidence supports the notion that early
activation of UPR signaling improves β-cell homeostasis in
glucolipoadaptation.Experimental Diabetes Research 3
4. ERStress under Glucolipotoxicity
Accumulating evidence suggests that glucolipotoxicity con-
tributestoβ-celldysfunctionduringthedevelopmentoftype
II diabetes. Chronic exposure of β-cellsto supraphysiological
levels of glucose or FFAs has been shown to be cytotoxic and
causes β-cell dysfunction and failure [28–30]. Briaud et al.
have provided evidence that lipotoxicity occurs in the pres-
ence of concomitantly elevated levels of glucose [31]. Sev-
eral mechanisms have been proposed for glucolipotoxicity-
induced β-cell dysfunction and failure, such as increased
ROS, ceramide, and nitric oxide levels, and mitochondrial
perturbations [32–34]. Recent evidence suggests that ER
stress is linked to insulin resistance in diabetes and also
expansion of ER was detected in β-cells from type II diabetic
patients [35, 36]. Furthermore, increased expression of ER
stress markers has been demonstrated in db/db mouse islets
andβ-cellsoftype2diabetespatients[23,36].Theseﬁndings
suggest that ER stress may be a pathophysiological event
responsible for β-cell dysfunction and failure in type II
diabetes.
Endoplasmic reticulum Ca2+ is an important signaling
molecule in the β-cell, and ﬂuctuations in Ca2+ levels in the
ER can aﬀect many functions of the endoplasmic reticulum,
including protein synthesis, processing, and interchaperone
interactions [37]. However, experimental data suggest that
saturated and, to a lesser extent, unsaturated FFAs, trigger
the ER stress response through depletion of ER Ca2+ stores
[26, 38, 39]. Several discrepancies appear in studies of FFA-
induced ER Ca2+ depletion, but the mechanism appears to
be similar to the direct eﬀects on sarcoplasmic-endoplasmic
reticulum Ca2+ ATPase-2b (SERCA) pump activity [39]. ER
Ca2+ depletion aﬀects protein folding in the ER, because
high luminal Ca2+ is essential for proteolytic processing and
foldingofproinsulin[37].Inaddition,palmitatecausesrapid
redistribution and degradation of carboxypeptidase E (CPE)
by depleting ER Ca2+. CPE is a soluble membrane-bound
enzyme in secretory granules involved in insulin processing.
Degradation of CPE by palmitate was found to cause
accumulation of unprocessed proinsulin in the secretory
pathway [40]. Along with depletion of ER Ca2+,p a l m i t a t e
also hampers ER-to-Golgi traﬃcking, as monitored using a
temperature-sensitive vesicular stomatitis virus G protein,
contributing to the accumulation of misfolded proteins and
impacting ER integrity and function [41].
5. UnfolDE(A)D ProteinResponse
As described above, elevated glucose and FFA act syn-
ergistically in causing pleiotropic eﬀects leading to β-cell
decompensation and apoptosis during type II diabetes. It
has been shown that palmitate induces β-cell dysfunction
and apoptosis via activation of ER stress. This activates the
UPR to restore normal ER function; when the UPR fails
to adequately restore ER function, it turns on signaling
pathways leading to apoptosis [42, 43]. The ER-localized
protein Bip/GRP78 is a multifunctional chaperone and
sensor of protein misfolding and controls activation of the
UPR response in ER stress. Bip/GRP78 is upregulated during
ERstress;overexpressionofBip/GRP78underhyperglycemic
conditions improves insulin levels and β-cell function [44].
In mouse MIN6 cells, Bip/GRP78 overexpression reduces
ER stress and partially protects cells against fatty acid-
induced apoptosis [23]. C/EBPbeta, a CCAAT/enhancer-
binding protein (C/EBP) family basic leucine zipper (bZip)
transcription factor, was found to be increased in diabetic
islets and to block the induction of Bip/GRP78 due to the
suppressed transactivation of ATF6α, thereby increasing the
vulnerability of β-cells to ER stress [45]. However, the role
of Bip/GRP78 under palmitate-induced ER stress is under
debate. In BRIN-BD11 cells, palmitate exposure does not
induce Bip/GRP78 [46]. These discrepancies may be depen-
dent on cell type, and a direct comparison between studies
would be required to understand the exact phenomenon that
happened under these experimental conditions.
As with Bip/GRP78, the eﬀects of palmitate on the
ATF6α pathway in β-cells are also controversial. Transient
transfection of INS-1 cells with HA-tagged ATF6α revealed
that ATF6α protein was distributed around the nucleus and
in the periphery of the cell in response to palmitate without
induction of Bip/GRP78, but not in control or oleate-treated
cells [47]. By contrast, Kharroubi et al. showed induction of
the ATF6α-GPR78 signaling pathway by palmitate in INS-
1 cells [48]. Recent evidence has also shown that missense
mutations and polymorphisms within ATF6α may be linked
to type II diabetes [49, 50]. Therefore, further studies are
in need to delineate the exact ATF6α signaling pathways
induced by palmitate in β-cell failure.
By contrast, mice with a PERK deletion develop diabetes
within a few weeks of birth due to progressive β-cell loss,
highlighting the importance of the PERK-mediated ER stress
response in the regulation of β-cell function and survival
[51]. Like other ER sensors, PERK is maintained in an
inactive state by binding to Bip/GRP78. Once activated,
PERKautophosphorylatesandcatalyzesthephosphorylation
of eif2α [52, 53]. This results in a general attenuation of
translation.Severalstudieshavedemonstratedthatpalmitate
and, to a lesser extent, oleate activate rapid phosphoryla-
tion of the PERK by depletion of ER calcium leading to
phosphorylation of eif2α, resulting in an overall decrease
in translation, but increased translation of selected proteins
includingATF3,ATF4,andCHOP[23,39,47,54].Induction
of ATF4 by upstream PERK-eif2α leads to the induction of
CHOP via binding of ATF4 to the C/EBP-ATF binding site in
theCHOPpromoter[55].InductionofA TF3,apr oapoptotic
protein, by palmitate leads to β-cell apoptosis [56]. In
addition, it has been shown that ATF3 downregulates the
expression of IRS-2 in β-cells [57]. By contrast, knockdown
of ATF3 was found to increase palmitate-induced apoptosis
insteadofprotectingagainstapoptosis[56].Recently,Zmuda
et al. showed that ATF3 knockout mice fed a high-fat diet
for 12 weeks had signiﬁcantly reduced serum insulin levels
without insulin sensitivity being aﬀected and without β-
cell apoptosis being induced [58]. So far, the downstream
targets of ATF3 in β-cells are not well known and further
investigation is needed to clarify these unexpected ﬁndings.
Expression of CHOP induced by palmitate induces cell
death through transcriptional regulation of survival and4 Experimental Diabetes Research
death eﬀectors. CHOP was found to be localized in the
nucleus as opposed to the cytoplasm in pancreatic sec-
tions from diabetic patients, suggesting that CHOP nuclear
translocation is a discrete and necessary step for apoptosis
induction [59]. CHOP also downregulates the expression
of the antiapoptotic protein Bcl-2 and increases cellular
reactive oxygen species, which likely contribute to ER stress-
associated cell death [60]. CHOP also upregulates expression
of ERO1α, an ER oxidase, causing hyperoxidizing conditions
in the ER leading to apoptosis [61, 62].
Growing evidence shows that the IRE1α-XBP-1 pathway
is activated in β-cells by palmitate treatment, but that it
is less sensitive to the monounsaturated fatty acid oleate
[46, 47, 54]. Oleate can eﬃciently counteract palmitate-
induced XBP-1 mRNA splicing, and knockdown of XBP-1
was shown to potentiate oleate- but not palmitate-mediated
β-cell apoptosis, suggesting diﬀerential activation of pro-
and antiapoptotic signals by downstream of IRE1α [63].
In this regard, IRE1α recruits the adaptor protein TNF
receptor-associated factor 2 (TRAF2) to the ER membrane,
leading to activation of JNK and downstream proapoptotic
signaling [64]. In rodent β-cells, the association of IRE1α
and TRAF2 contributes to ER-triggered apoptosis [65, 66].
Increased levels of saturated FFAs lead to JNK activation,
IRS1 and IRS2 ser/thr phosphorylation, and downregulation
of insulin signaling and gene expression [67]. Furthermore,
inactivation of JNK in β-cells prevents palmitate-induced
inhibition of insulin gene expression [68]. In addition,
blockade of palmitate-induced activation of JNK using a
JNK inhibitor partially protected β-cells from the eﬀects of
palmitate [64]. However, the downstream mechanism by
which JNK leads to apoptosis is not clear, and this may be
mediated via caspase activation, which is described in the
next section (Figure 1).
6.ERisLinkedtoMitochondriato
Induce Apoptosis
The ER and mitochondria are capable of modifying their
structure and function in response to changing environ-
mental challenges. These two organelles form a highly
dynamic interconnected network for activating apoptosis
[69]. However, the regulatory mechanisms, which determine
cell status leading to cell survival or cell death in response
to ER stress, have not been well established. Mitochondria
have a heterogeneous shape among diﬀerent cell types and
their ability to eﬀectively function is inﬂuenced by their
dynamic behavior. Interestingly, mitochondrial shape and
morphology are determined by two dynamically opposed
processes: fusion and ﬁssion. Ablation of both fusion and
ﬁssion produces a profound eﬀect on the progression of cells
toapoptosis[70].Ithasbeenshownthatthemitochondriaof
β-cells from Zucker diabetic rats are fragmented, suggesting
an imbalance in the regulation of mitochondrial fusion and
ﬁssion [71]. Under normal conditions, mitochondria in β-
cells continuously undergo fusion and ﬁssion and these
interactions may function to negate the detrimental eﬀects
of long-term exposure of β-cells to palmitate under high-
glucose conditions, causing mitochondrial fragmentation
and impairing network dynamics by abolishing fusion and
ﬁssion activity. However, in the absence of palmitate, high
glucose does not aﬀect mitochondrial architecture [72].
Ithasbeenclearlydemonstratedthatapoptosisinduction
leads to fragmentation of the mitochondrial network. More-
over, inhibition of mitochondrial ﬁssion by Fis1, an outer
mitochondrial membrane ﬁssion protein that determines
the frequency of mitochondrial ﬁssion, reduced apoptosis
in β-cells [72]. This has been questioned by another study,
which ruled out the possibility that fragmentation occurs
early in the cell death pathway [73]. These conﬂicting results
may be reconciled by the fact that mitochondria are able
to receive diﬀerent stress signals and integrate them. How,
then, do high-fat glucose conditions promote mitochondrial
fragmentation and apoptosis? It is assumable that crosstalk
between the ER and mitochondria may determine cellular
commitment to apoptosis through Ca2+.E x p o s u r eo fβ-
cells to high-fat glucose conditions causes release of Ca2+
from the ER to the cytoplasm, leading to a rise in cytosolic
Ca2+ concentration that reﬂects increased mitochondrial
Ca2+ uptake. Increased mitochondrial Ca2+ uptake enhances
local buﬀering capacity and release of proteins capable
of apoptosis activation [74]. Subsequently, Ca2+ activates
the phosphatase calcineurin, which dephosphorylates and
inactivates dynamin-related protein 1 (Drp1), a master reg-
ulator of mitochondrial ﬁssion. Interestingly, inhibition of
calcineurin activation partially prevented palmitate-induced
apoptosis [75]. In addition, palmitate-induced activation
of mitochondrial transition pores caused depolarization
of the mitochondrial inner membrane and cytochrome c
release into the cytosol, which stimulates the assembly of
the apoptosome leading to activation of caspase-9, which,
in turn, activates caspase-3, leading to DNA fragmentation
and cell death [63, 64, 76, 77]. Moreover, mitochondrial
cytochrome c translocates to the ER, where it selectively
binds to InsP3R, leading to a sustained rise in cytosolic Ca2+
[78].
In addition, the Bcl-2 family of proteins has a role
in mediating ER stress-induced apoptosis. Under normal
conditions, Bcl-2 can bind and sequester BH3-only proteins,
preventing these proteins from triggering oligomerization
and activation of Bax and Bak [79]. Upon stimulation,
Bax translocates from the cytosol to the mitochondria and
oligomerizes with Bak, resulting in mitochondrial outer
membrane permeabilization and release of cytochrome c
into the cytosol [80, 81]. Mcl-1, a member of the anti-
apoptotic Bcl-2 protein family, prevents Bax activation and
translocation by sequestering factors contributing to Bax
translocation [81]. Allagnat et al. recently demonstrated
that, under lipotoxic conditions, Mcl-1 expression was
downregulated in β-cells leading to translocation of Bax
into mitochondria, cytochrome c release, and caspase-
3 cleavage and apoptosis [82]. However, supporting this
concept, another study has suggested the involvement of
translationally controlled tumor protein (TCTP) with no
sequence similarity to any other known protein. TCTP binds
to antiapoptotic proteins in the Bcl-2 family, such as Mcl-
1 and Bcl-XL, and antagonizes apoptosis by enhancing the
antiapoptotic actions of these proteins [83]. Diraison etExperimental Diabetes Research 5
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Figure 1: FFA-induced endoplasmic reticulum stress transduction and apoptosis in pancreatic β-cells, and its mechanisms; how FFA elicits
β-cell apoptosis is discussed in detail in the text.
al. showed that, in β-cells, glucose regulates the expression
of TCTP and its translocation from the cytosol to the
nucleus by phosphorylation and glucose levels inﬂuence the
sensitivity of β-cells to apoptosis. Palmitate treatment of β-
cells decreased TCTP, resulting in increased β-cell death,
and overexpression of TCTP prevented β-cell death. These
authors also demonstrated that TCTP partially translocates
to the mitochondrion in response to glucose. But it is not
clear how glucose regulates TCTP translocation to various
organelles and protects cells from apoptotic stimuli [84].
In addition, as described previously, FFA-induced acti-
vation of CHOP and JNK pathways decreased expression
and increased the phosphorylation of Bcl-2, respectively [63,
76, 85, 86]. Phosphorylated Bcl-2 also enhances Ca2+ eﬄux
from the ER and increases Ca2+ uptake by mitochondria
[87]. Indeed, overexpression of Bcl-2 can inﬂuence the
distributionofCa2+ withintheERandmitochondriaandcan
protect against apoptosis [88–90]. Together, these ﬁndings
suggesttheexistenceofanovelpathwayinvolvingtheERand
mitochondria, through which these organelles orchestrate
the regulation of death signals. In this complex scenario,
further understanding of this link should give insights
valuable for the identiﬁcation of therapeutic targets to
protect β-cell function and prevent type II diabetes.
7. Therapeutic Agents Targeted to the ER
ER stress has been found to be associated with obesity,
insulinresistance,andtypeIIdiabetes.Therefore,agentsthat
reduce ER stress are useful in treating obesity, peripheral
insulin resistance, and hyperglycemia and type II diabetes.
These agents reduce or prevent ER stress by improving
the folding or processing capacity of the ER. Chemical
chaperones such as PBA and TUDCA have been shown to
regulate ER stress and improve insulin sensitivity in vivo
[91]. In addition, salubrinal, a selective inhibitor of eif2α
dephosphorylation, has been proposed as a novel therapy
for diabetes. Salubrinal blocks eif2α dephosphorylation
mediated by herpes simplex virus protein and inhibits viral
replication [92]. But, in β-cells, selective inhibition of eif2α
was found to potentiate lipotoxicity [27].
A growing body of evidence suggests that glucagon-like
peptide 1 (GLP-1) andits analogues ameliorate experimental
diabetes and preserve β-cell mass, protecting β-cells from
apoptosis [93–95]. Activation of GLP-1 receptor by exendin-
4 was shown to improve the survival of β-cells exposed
to chemically induced ER stress via increased ATF4-CHOP
expression. Interestingly, upon exposure to lipotoxic condi-
tions, GLP-1 receptor activation prevented β-cell apoptosis
by increasing cellular defense through the induction of
Bip/GPR78 and the antiapoptotic protein junB [63].
Recently, in a search for novel therapeutic agents,
plant-derived ﬂavonoids were found to exhibit a broad
spectrum of bioactivities. They display a remarkable array
of biochemical and pharmacological actions, which may
signiﬁcantly aﬀect the functions of various cellular systems
[96]. Among ﬂavonoids, methoxyﬂavonoids have beneﬁcial
hypolipidemic eﬀe c t sa n ds u p p r e s sE Rs t r e s sb o t hin vivo6 Experimental Diabetes Research
and in vitro [97, 98]. In addition, quercetin, a ﬂavonoid
foundinmanyplants,protectsβ-cellsfromoxidativedamage
and preserves β-cell integrity [99, 100]. Several studies have
demonstrated that the isoﬂavone genistein, isolated from
legumes, has antidiabetic eﬀects presumably mediated by
hypolipidemic eﬀects, thereby increasing insulin sensitivity.
Administration of genistein to animal and human islets
increased islet proliferation, survival, and mass, mediated
by activation of cAMP/PKA/ERK1/2 phosphorylation [101–
103]. To date, the beneﬁcial activities of ﬂavonoids have been
attributed mainly to their antioxidant properties. Detailed
studies are needed to reveal the mechanisms beyond antioxi-
dantactivityunderlyingthebeneﬁcialeﬀectsofﬂavonoidson
the ER-mitochondrial connection in the apoptotic cascade.
8. Conclusion
It is known from experimental evidence that ER stress
contributes to tissue dysfunction and damage caused by
glucolipotoxicity in diabetes. However, the mechanisms
underlying β-cell dysfunction and death in diabetes are
complex. Understanding this complex scenario and the
agents that modulate the ER stress response to β-cell
resistance to lipotoxic stress could have considerable impact
on the treatment of β-cell failure and type II diabetes. Thus,
additional studies are required to determine the link between
ER stress and β-cell failure. This may potentially lead to
the development of novel therapeutics to prevent type II
diabetes.
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